Validating a Patient-Reported Comorbidity Measure with Respect to Quality of Life in End-Stage Renal Disease.
PURPOSE:Medical record-derived comorbidity measures such as the Charlson Comorbidity Index (CCI) do not predict functional limitations or quality of life (QoL) in the chronically ill. Although these shortcomings are known since the 1980s, they have been largely ignored by the international literatur...
Main Authors: | Maxi Robinski, Franz Strich, Wilfried Mau, Matthias Girndt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4905653?pdf=render |
Similar Items
-
Tracking Visual Scanning Techniques in Training Simulation for Helicopter Landing
by: Maxi Robinski, et al.
Published: (2013-07-01) -
Health-Related Quality of Life Based on Comorbidities Among Patients with End-Stage Renal Disease
by: Jieun Cha, et al.
Published: (2020-08-01) -
Angiopoietin-2 and Mortality Outcomes in End-Stage Renal Disease with Heart Failure as a Comorbidity
by: Vanessa Robbin BS, et al.
Published: (2024-12-01) -
Activation of oxidative stress, comorbidity and survival of end-stage renal disease patients treated with hemodialysis
by: I. Shifris, et al.
Published: (2021-08-01) -
Background Activity Findings in End-Stage Renal Disease With and Without Comorbid Diabetes: An Electroencephalogram Study
by: Tirapoot Jatupornpoonsub, et al.
Published: (2021-10-01)